Real world experience of Ocrelizumab in MS in the Turkish population: A single-center study
MS Days VII, Nevşehir, Turkey, 9 - 11 March 2022, (Full Text)
- Publication Type: Conference Paper / Full Text
- City: Nevşehir
- Country: Turkey
- Bursa Uludag University Affiliated: Yes